You are here

All Bluffton Icon News

Pandora Community VBS next week 7-11 July

at Pandora Missionary Church

The churches of Pandora are conducting a Community VBS program next week, Sunday through Thursday, July 7-11, at Pandora Missionary Church from 6:30 to 8:45 p.m.

This year's theme "In the Wild" looks at amazing encounters with Jesus. This five-day program will be packed with songs, fun, games and bible stories. This VBS program is for youth ages five through sixth grade. 

Pandora Mission Church is located at 300 Rocket Ridge, Pandora.

For more information, please got to http://pandoramissionarychurch.org.

Section: 

They are going to tumble, play basketball and volleyball at BFR in July

And, there's still time to sign-up

Camps and clinics in July and sign-up is now underway, according to Daniel Tinch, BFR executive director.

Tumbling Clinic
Monday-Tuesday-Wednesday, July 8-9-10
Ages 3-5, 10-11 a.m.
Ages 5-8, 10 a.m.-noon
$15 members; $30 non-members

6-8 grade basketball camp
Monday-Tuesday-Wednesday-Thursday, July 15-16-17-18
1-3 p.m.
T-shirt included if registered by July 1
$20 members; $40 non-members

18 caps

This photo needs a little explanation, but it's worth a second look. Here are 18 caps. You'll find these hanging in the Spring Street village building. The Icon stopped by last week and saw the caps and couldn't resist taking this photo. Where else in Bluffton are 18 caps in a row?

15 minutes with Jenny (Sylak) Goodrich

Music teacher and softball coach in the UP; took her team to the regional finals

Icon: We understanding you are a high school teacher and softball coach.
Jenny: I teach and coach at Bark River-Harris High School in Michigan.

Icon: Where is it on the Michigan map?
Jenny: It’s in Harris, Michigan, about 10 miles northwest of Escanaba in Michigan's Upper Peninsula. About 10 hours from Bluffton.

Section: 

Another biosimilar to Herceptin

FDA approves new drug that treats breast, stomach and esophageal cancer

Note: this article was provided by ONU Healthwise Pharmacy. 
The US Food and Drug Administration (FDA) has approved another biosimilar to a drug that treats breast, stomach and esophageal cancer.

This biosimilar is called Kanjinti (trastuzumab-anns). The FDA approved it because it appeared to have no meaningful differences from Herceptin (trastuzumab), which has already been approved.

Section: 

Jeff Gundy offers free Writing Workshop at Bluffton library on July 9th

Professor Gundy will discuss his family history research as well as his upcoming memoir, Wind Farm. Time for writing to follow. Register today!

Interested in Creative Nonfiction including memoirs, biographies, and family histories?

Pages